Long-term outcome and predictors of long-term disease activity in natalizumab-treated patients with multiple sclerosis: real life data from the Austrian MS Treatment Registry

OBJECTIVES: To evaluate long-term effectiveness of natalizumab (NTZ) and to determine demographic, clinical, and radiological predictors regarding long-term disease activity (≥ 7 years) in a nationwide observational cohort, using data collected prospectively in a real-life setting. MATERIALS AND MET...

Descripción completa

Detalles Bibliográficos
Autores principales: Guger, Michael, Enzinger, Christian, Leutmezer, Fritz, Di Pauli, Franziska, Kraus, Jörg, Kalcher, Stefan, Kvas, Erich, Berger, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Original Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8505366/
https://www.ncbi.nlm.nih.gov/pubmed/33890167
http://dx.doi.org/10.1007/s00415-021-10559-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8505366/
https://www.ncbi.nlm.nih.gov/pubmed/33890167
http://dx.doi.org/10.1007/s00415-021-10559-w

Ejemplares similares